neuraxpharm Arzneimittel GmbH
- Legal form
- GmbH
- Seat
- Langenfeld, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 5 October 2026.
Identifiers
As the covered sources state them.
- Register entry
- HRB 93523
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 7 | — | 1 | 1 | 5 October 2026 | 5 October 2026 |
Awards
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
- Ersatzkassen-Generika Nr. 31 (Bekanntmachung vergebener Aufträge)Buyer: Techniker Krankenkasse · Awarded: 5 October 2026 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
- Website
- http://neuraxpharm.com/declared in a notice
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderEstablished supplier
Open-House-Rabattverträge 2025-07
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 6 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 6 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 14:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open-House-Rabattverträge 2024-11
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 6 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 6 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 14:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Open-House-Originale-Rabattverträge 2026-14 Crizotinib
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 6 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 6 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 15:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
1/DLII6/VM154 - RV Arzneimittel, divers
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 31 Oct 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 31 Oct 2026
Last checked 6 Nov 2026, 14:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
1/DLII6/VM076_RV_INFLUENZA-IMPFSTOFF_hochdosiert
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
1/DLII6/VM131 - RV div. Arzneimittel
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 2 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 2 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
36. Generikaausschreibung (Antibiotika)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
36. Generikaausschreibung (1er)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
36. Generikaausschreibung (2/3er)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 3 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 3 Nov 2026
Last checked 27 Oct 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderEstablished supplier
Patent_95.1_Aripiprazol_Abilify (Maintena)
Reasons
- Won a contract in CPV group 336 (2026-10-05) Evidence · checked 4 Nov 2026
- Seat in the same region as the place of performance Evidence · checked 4 Nov 2026
- 7 awards in this field in 36 months, from 1 buyer Evidence · checked 4 Nov 2026
Last checked 26 Oct 2026, 15:47 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 5 October 2026.